Call for Abstracts



Download the submission guidelines here:

Award Details

Oral presentation at the annual, national VIRTUAL Meeting of the Minds conference on Saturday, November 7, 2020 (15 minutes presentation plus 5 minutes Q&A)


  • MDs: Must currently be in an advanced IBD Fellowship and/or not more than 5 years post-graduation

  • PhDs: Must have completed PhD in an IBD-related field, i.e. immunology, biochemistry, molecular biology not more than 5 years ago

General Information

The deadline for submission of abstracts is Monday, September 28, 2020 at 11:59 pm Eastern Time. This deadline will be strictly enforced and NO EXCEPTIONS will be made. All abstracts must be submitted by email to

Preparing the Submission

Abstracts must be submitted in English, and must relate to clinical or research-oriented work in the field of inflammatory bowel disease (IBD).

Abstract Authors

The maximum number of authors is 20. Enter all authors in the order they should appear in the heading of the abstract. The submission must also include the location of the institution where the work was done.

Presenting Author

The awardee must present the abstract personally.

Character Limit

The body of the abstract is limited to 2,500 characters, including spaces.

Abstract Title

The title should be concise and clearly reflect the content of the abstract. The title should be entered in title case, not in all capital letters. Do not use formatting tags in the title.

Abstract Body/Text

Standard study abstracts describing original research or clinical trials must include the following sections: Introduction, Methods, Results, Discussion. Do not include any of the following author information within the abstract body: direct or indirect reference to author institution(s), titles, positions, or institutional appointments. Abstracts must be submitted in word.doc or word.docx using Arial 11pt, 1.5 line spacing. PDF files will not be accepted.


Standard abbreviations may be used, i.e., RBC, gm, kg, mg, mL, % (percent), / (per).

Industry Support, Disclosures, and Conflict of Interest (COI)

Abstract presenters are required to disclose whether the research was funded by an industry grant from a commercial interest, AND must also complete the conflict of interest disclosure form, indicating details of support any authors may have received or affiliations any authors may have with a commercial interest.

Abstract Review Process

Immediately following the abstract submission period, all submitted abstracts are blind reviewed and scored by a team of reviewers. Each abstract is reviewed by up to 4 reviewers. Reviewers consider the following when scoring abstracts: relevance, novelty, quality, clarity, organization, design, and data analysis. Following review by the MotM Abstract Selection Committee highest-rated abstract presenter will be notified by email by October 12, 2020.


  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.